Sfoglia per Autore
Fractional exhaled nitric oxide in acute exacerbations of chronic obstructive pulmonary disease: A meta-analysis with meta-regressions
2025 Ambrosino, P; Candia, C; Zamparelli, S; Marcuccio, G; Manzo, F; Spedicato, G; Basile, C; Mancusi, C; Lubrano, E; Grassi, G; Motta, A; Maniscalco, M
Effect of nebivolol monotherapy or combination therapy on blood pressure levels in patients with hypertension: an updated systematic review and multilevel meta-analysis of 91 randomized controlled trials
2025 Manolis, A; Karakasis, P; Patoulias, D; Doumas, M; Kallistratos, M; Thomopoulos, C; Koutsaki, M; Grassi, G; Mancia, G
FAILURE OF ANTIHYPERTENSIVE TREATMENT TO RESTORE NORMAL SYMPATHETIC ACTIVITY
2025 Massabò, D; Quarti-Trevano, F; Seravalle, G; Facchetti, R; Dell'Oro, R; Tsioufis, K; Dimitriadis, K; Manta, E; Mancia, G; Grassi, G
IMPACT OF ELEVATED BLOOD PRESSURE ON CARDIAC MECHANICS IN CHILDREN AND ADOLESCENTS: A SYSTEMATIC REVIEW AND META-ANALYSIS
2025 Faggiano, A; Gherbesi, E; Sala, C; Carugo, S; Grassi, G; Tadic, M; Cuspidi, C
BLOOD PRESSURE VARIABILITY ALTERS CEREBRAL FUNCTIONAL NETWORKS CONNECTIVITY IN HYPERTENSIVE PATIENTS
2025 Carnevale, L; Maffei, A; Quarti-Trevano, F; Carnevale, D; Grassi, G; Lembo, G
Elevated Blood Pressure And Cardiac Mechanics In Children And Adolescents: A Systematic Review And Meta-Analysis
2025 Faggiano, A; Gherbesi, E; Sala, C; Carugo, S; Grassi, G; Cuspidi, C; Tadic, M
Global Effect of Cardiovascular Risk Factors on Lifetime Estimates
2025 Magnussen, C; Alegre-Diaz, J; Al-Nasser, L; Amouyel, P; Aviles-Santa, L; Bakker, S; Ballantyne, C; Bernabé-Ortiz, A; Bobak, M; Boffetta, P; Brenner, H; Brunström, M; Can, G; Carrillo-Larco, R; Checkley, W; Dallongeville, J; De Bacquer, D; De Gaetano, G; De Lemos, J; Di Carluccio, E; Dobson, A; Donfrancesco, C; Dörr, M; D'Orsi, E; Drygas, W; Dullaart, R; Engström, G; Ferrario, M; Ferrières, J; Figtree, G; Gaye, B; Ghayour-Mobarhan, M; Goldbourt, U; Gonzalez, C; Gossling, A; Grassi, G; Gupta, P; He, J; Hodge, A; Hozawa, A; Hveem, K; Iacoviello, L; Ikram, M; Inoue, M; Irazola, V; Jobe, M; Jousilahti, P; Kaleebu, P; Kavousi, M; Kee, F; Khalili, D; Klotsche, J; Koenig, W; Kontsevaya, A; Kowlessur, S; Kuri-Morales, P; Kuulasmaa, K; Kweon, S; Lackner, K; Landmesser, U; Leistner, D; Leiva Sisnieguez, C; Leong, D; Lind, L; Linneberg, A; Lorenz, T; Lyngbakken, M; Malekzadeh, R; Malyutina, S; Mathiesen, E; Mcelduff, P; Melander, O; Metspalu, A; Miranda, J; Moitry, M; Mugisha, J; Munzinger, J; Nalini, M; Nambi, V; Nilsson, P; Ninomiya, T; Omland, T; Ong, S; Oppermann, K; Pajak, A; Palmieri, L; Panagiotakos, D; Park, S; Pednekar, M; Perianayagam, A; Peters, A; Poustchi, H; Prabhakaran, D; Prentice, A; Prescott, E; Quyyumi, A; Risérus, U; Sakata, S; Salazar, M; Salomaa, V; Sans, S; Sattler, E; Schöttker, B; Schutte, A; Sepanlou, S; Sharma, S; Shaw, J; Simons, L; Söderberg, S; Tamosiunas, A; Tapia-Conyer, R; Thorand, B; Tunstall-Pedoe, H; Tuomilehto, J; Twerenbold, R; Vanuzzo, D; Veronesi, G; Wannamethee, S; Watanabe, M; Weimann, J; Wild, P; Yao, Y; Zeng, Y; Ziegler, A; Ojeda, F; Blankenberg, S
Serum Uric Acid in the PAMELA Study: Main Findings and Association with the Atherogenic Index of Plasma
2025 Maloberti, A; Facchetti, R; Cuspidi, C; Grassi, G
Rationale for the Use of Fixed Combination Therapies with Angiotensin Converting Enzyme Inhibitors and Beta-Blockers in Patients with Essential Hypertension and High Cardiovascular Risk: A Consensus Document from the Italian Society of Arterial Hypertension (Siia) and the Italian Society of Cardiovascular Prevention (SIPREC)
2025 Virdis, A; Tocci, G; Muiesan, M; Desideri, G; Viazzi, F; Albini, F; Sarzani, R; Giovanna, G; Grassi, G; Volpe, M
The Big Data Era in Cardiology and Cardiovascular Medicine: Advanced Analytics for Truly Personalized Care
2025 Ambrosino, P; Manzo, F; Candia, C; Spedicato, G; Grassi, G; Maniscalco, M
Connecting Cardiovascular Risk Scores With Hypertensive Mediated Organ Damage
2025 Cuspidi, C; Tadic, M; Grassi, G
The saga of the guidelines on hypertension: Focus on the 2025 ACC/AHA document
2025 Grassi, G
When should antihypertensive drug treatment be started? Discrepancies between the 2023 European Society of Hypertension and the 2024 European Society of Cardiology guidelines
2025 Mancia, G; Grassi, G; Kjeldsen, S
Orthostatic Hypertension in Childhood: Filling the Gap of Information on the Phenotype
2025 Stabouli, S; Grassi, G
2025 National Congress of the Italian Society of Hypertension
2025 Grassi, G
Association Between Arterial Stiffness, High Blood Pressure, and Hypertensive Phenotypes: Insights from the PAMELA Study
2025 Quarti-Trevano, F; Cuspidi, C; Dell'Oro, R; Ambrosino, P; Grassi, G
Pulse Wave Velocity Assessment: A Useful Tool to Screen Asymptomatic Individuals at High Cardiovascular Risk?
2025 Pucci, G; Alcidi, R; Grassi, G
Occurrence of coronary events in the absence of traditional risk factors: Understanding residual risk
2025 Arnold, N; Goßling, A; Weimann, J; Bay, B; Zeller, T; Ferrario, M; Palmieri, L; Amouyel, P; Moitry, M; Ferrières, J; Brenner, H; Tamosiunas, A; Malyutina, S; Männistö, S; Drygas, W; Grassi, G; Grimsgaard, S; Linneberg, A; Söderberg, S; Iacoviello, L; Sans, S; Schnabel, R; Veronesi, G; Thorand, B; Tunstall-Pedoe, H; Kee, F; Salomaa, V; Kuulasmaa, K; Blankenberg, S; Waldeyer, C; Ojeda, F; Magnussen, C; Koenig, W
Prevalence, awareness, and control of cardiovascular risk factors among specialists in cardiovascular field: A survey
2025 Rosei, C; Pinto, R; Muiesan, M; Ferri, C; Grassi, G
High Heart Rate, Sympathetic Overdrive, And Cardiovascular Risk In Hypertension
2025 Grassi, G; Ram, C; Palatini, P
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile